KYINNO BIOTECHNOLOGY Inc.

KYINNO is dedicated to oncology drug discovery service and customized product development, with a focus on immuno-oncology and next-generation kinase inhibitor discovery. With a distinctive portfolio of cell lines, KYinno provides comprehensive services to boost your drug discovery. KYinno does engineered cell line construction, in vitro compound IC50 measurement, in vivo drug efficacy evaluation, hybridoma antibody preparation, and humanized antibody design and development. Our service platforms include: - Engineered custom cell line development - Cell-based assay validation and compound screening - Phage display library and hybridoma technology for antibody drug discovery - Cancer cell panel compound profiling and biomarker discovery Our products include: - Engineered reporter cell lines - Antibody and proteins with fully validated functions in reporter cell lines Our team members have years of experience in the pharmaceutical and biotechnology industry in both China and U.S.